New York Oncology Hematology P.C. is a clinical research site located in Albany, New York, United States 12208.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
New York Oncology Hematology P.C. has participated in 8 clinical trials with 1 currently active.
Therapeutic areas: Neoplasms, Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin.
Sponsors: Adherex Technologies, Inc., Juno Therapeutics, a Subsidiary of Celgene, Celgene.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
New York Oncology Hematology P.C. has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Oncology Hematology P.C. has 8 clinical trials on record, with 1 currently active. Their work covers Neoplasms, Lymphoma, Non-Hodgkin, Lymphoma, Nonhodgkin.
Yes — New York Oncology Hematology P.C. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.